Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
3.750
+0.090 (2.46%)
Oct 8, 2025, 2:08 PM EDT - Market open
Nuvation Bio Stock Forecast
Stock Price Forecast
The 7 analysts that cover Nuvation Bio stock have a consensus rating of "Strong Buy" and an average price target of $8.43, which forecasts a 124.80% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $10.
Price Target: $8.43 (+124.80%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +166.67% | Sep 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +166.67% | Sep 19, 2025 |
| Wedbush | Wedbush | Buy Reiterates $6 | Buy | Reiterates | $6 | +60.00% | Sep 8, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +86.67% | Aug 8, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +60.00% | Jun 25, 2025 |
Financial Forecast
Revenue This Year
34.07M
from 7.87M
Increased by 332.80%
Revenue Next Year
156.78M
from 34.07M
Increased by 360.12%
EPS This Year
-0.66
from -2.11
EPS Next Year
-0.56
from -0.66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 48.1M | 220.1M | |||
| Avg | 34.1M | 156.8M | |||
| Low | 20.7M | 77.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 510.8% | 545.9% | |||
| Avg | 332.8% | 360.1% | |||
| Low | 162.7% | 127.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.63 | -0.20 | ||
| Avg | -0.66 | -0.56 | ||
| Low | -0.68 | -0.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.